Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
Spear Bio has raised $45.0M in total funding. The most recent round was Series A. The last funding was announced in July 2024.
Spear Bio's investors include HSG, CDH Investments, Maverick Ventures, Foresite Capital, Bio-Techne.
Spear Bio is headquartered in Weston, United States.
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
Spear Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spear Bio — Funding & Investors." VCBacked, July 29, 2024, https://www.vcbacked.co/company/spear-bio. Accessed July 20, 2026.
VCBacked. (2024). Spear Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/spear-bio
{{cite web |title=Spear Bio — Funding & Investors |url=https://www.vcbacked.co/company/spear-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated